Welcome to LookChem.com Sign In|Join Free
  • or
1-bromo-4-[(4-methoxyphenyl)methoxy]but-2-yne is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

266675-30-3

Post Buying Request

266675-30-3 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

266675-30-3 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 266675-30-3 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 2,6,6,6,7 and 5 respectively; the second part has 2 digits, 3 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 266675-30:
(8*2)+(7*6)+(6*6)+(5*6)+(4*7)+(3*5)+(2*3)+(1*0)=173
173 % 10 = 3
So 266675-30-3 is a valid CAS Registry Number.

266675-30-3Relevant academic research and scientific papers

TAU-PROTEIN TARGETING COMPOUNDS AND ASSOCIATED METHODS OF USE

-

Paragraph 1193; 1194; 1448; 1449, (2021/02/12)

The present disclosure relates to bifunctional compounds, which find utility as modulators of tan protein. In particular, the present disclosure is directed to bifunctional compounds, which contain on one end a VHL or cereblon ligand which binds to the E3 ubiquitin ligase and on the other end a moiety which binds tan protein, such that tan protein is placed in proximity to the ubiquitin ligase to effect degradation (and inhibition) of tan. The present disclosure exhibits a broad range of pharmacological activities associated with degradation/inhibition of tan protein. Diseases or disorders that result from aggregation or accumulation of tan protein are treated or prevented with compounds and compositions of the present disclosure.

TAU-PROTEIN TARGETING PROTACS AND ASSOCIATED METHODS OF USE

-

Paragraph 1476-1477, (2018/05/24)

The present disclosure relates to bifunctional compounds, which find utility as modulators of tau protein. In particular, the present disclosure is directed to bifunctional compounds, which contain on one end a VHL or cereblon ligand which binds to the E3 ubiquitin ligase and on the other end a moiety which binds tau protein, such that tau protein is placed in proximity to the ubiquitin ligase to effect degradation (and inhibition) of tau. The present disclosure exhibits a broad range of pharmacological activities associated with degradation/inhibition of tau protein. Diseases or disorders that result from aggregation or accumulation of tau protein are treated or prevented with compounds and compositions of the present disclosure.

Tandem cycloaddition reactions of allenyl diazo compounds forming triquinanes via trimethylenemethane diyls

Kang, Taek,Kim, Won-Yeob,Yoon, Yeokwon,Kim, Byung Gyu,Lee, Hee-Yoon

supporting information; experimental part, p. 18050 - 18053 (2011/12/13)

A tandem reaction strategy for forming triquinanes from linear allenyl diazo compounds through an intramolecular 1,3-dipolar cycloaddition reaction of an allenyl diazo group that generates a trimethylenemethane (TMM) diyl followed by an intramolecular [2

New approach to β-lactam-fused enediynes ('Lactenediynes') by stereoselective pinacol coupling

Banfi, Luca,Guanti, Giuseppe,Basso, Andrea

, p. 939 - 946 (2007/10/03)

A short synthesis of unfunctionalized lactenediyne 3 by closure of the ten-membered ring at the double bond site is reported. After failure of the known methodologies, this closure was eventually successfully achieved thanks to a highly stereoselective, v

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 266675-30-3